Moving Biotech receives US FDA’s IND clearance for 4P004; strengthens its position as a leading innovator in disease-modifying osteoarthritis therapeutics: Lille, France Saturd ...

Our first biotech bi-weekly of 2026 is here with recent innovations in genomic drug discovery, organoid development and ADC ...

NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

LOR is the first drug candidate with disease-modifying potential for osteoarthritis submitted for approval, demonstrating ...

Delhi HC requests CBI's response to Lalu Prasad's plea against charge framing in the IRCTC scam, trial continues.

The Erasmus Mundus Joint Master (EMJM) Bioceb programme has opened applications for its 2026–2028 intake. Bioceb is a ...

Ruthenium has emerged as a pivotal metal in modern medicine, drug discovery, and biotechnology, with its integration into ...

Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial ...

Beauty is often thought of as surface-deep. But what we put on our skin and how it’s made has ripple effects beyond just our skin. At Credo Beauty, we’ve been thinking about beauty in the context of ...

Polaroid-style cards for movies discussed in the article including “Dune: Part Two” (2024), “Jurassic World: Rebirth” (2025) and “I Am Legend” (2007). While films like “Arrival” (2016) consult experts ...

• Buck Institute’s deployment of Nautilus’ instrument generates tau proteoform data, providing external validation of the company’s next-generation single-molecule proteomics platform • Joint research ...